Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023 12-05-2023, 12:00

Classic Parade announces its incorporation as an LTD company 27-03-2023, 21:36

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00